Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. German Humalog-CSII Study Group. - Concepedia

Concepedia

Publication | Closed Access

Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. German Humalog-CSII Study Group.

168

Citations

0

References

1999

Year

R. Renner, Andreas Pfützner, Michael Trautmann, Oliver Harzer, K Sauter, R Landgraf

Abstract

Insulin lispro is a suitable and very convenient pump insulin that may result in an improvement of long-term glucose control during CSII treatment. Its safety profile does not differ from that of regular human insulin.